Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?

被引：0

作者：

Thomas Foret

Virginie Dufrost

Lucie Salomon Du Mont

Patricia Costa

Benjamin Lefevre

Patrick Lacolley

Veronique Regnault

Stephane Zuily

Denis Wahl

机构：

[1] Université de Lorraine,INSERM UMR_S 1116 DCAC and CHRU

[2] INSERM,Nancy, Vascular Medicine Division and Regional Competence Center for Rare Auto

[3] DCAC,Immune Vascular Diseases

[4] CHRU-Nancy,undefined

[5] Vascular Medicine Division and Regional Competence Center for Rare Vascular and Systemic Autoimmune Diseases,undefined

[6] CHRU-Besancon,undefined

[7] Vascular and Endovascular Surgery Department,undefined

[8] Université de Bourgogne Franche-Comté,undefined

[9] EA3920,undefined

[10] CHRU-Besancon,undefined

[11] Vascular Medicine Unit,undefined

[12] Vascular and Endovascular Surgery Department,undefined

[13] Université de Lorraine,undefined

[14] CHRU-Nancy,undefined

[15] Infectious and Tropical Diseases,undefined

[16] Université de Lorraine,undefined

[17] APEMAC,undefined

[18] University of Lorraine,undefined

[19] INSERM,undefined

[20] University Hospital (CHRU) of Nancy,undefined

来源：

Current Rheumatology Reports | 2021年 / 23卷

关键词：

Antiphospholipid antibodies; Lupus anticoagulant; Thrombosis; COVID-19;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Antiphospholipid antibodies in patients with stroke during COVID-19: A role in the signaling pathway leading to platelet activation
Capozzi, Antonella
Riitano, Gloria
Recalchi, Serena
Manganelli, Valeria
Longo, Agostina
Falcou, Anne
De Michele, Manuela
Garofalo, Tina
Pulcinelli, Fabio M.
Sorice, Maurizio
Misasi, Roberta
FRONTIERS IN IMMUNOLOGY, 2023, 14
[22] Antiphospholipid Antibodies In Covid-19 Convalescent Plasma
Becicka, Wyatt
Berreby, Gil
Wang, Jintao
Moitra, Jaideep
Panicker, Sumith
Tourdot, Benjamin
Norris, Philip
Kelly, Kathleen
Zouo, Yu
Dumont, Larry
Knight, Jason
Kanthi, Yogendra
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2022, 42
[23] Evaluating the Relationship Between Antiphospholipid Antibodies and COVID-19 Severity
Sadeghi, Alireza
Hasanlu, Masumeh
Feyzi, Abdolamir
Mansori, Kamyar
Ghodrati, Samad
Parsamanesh, Negin
DNA AND CELL BIOLOGY, 2023, 42 (01) : 65 - 71
[24] Antiphospholipid antibodies in critically ill COVID-19 patients with thromboembolism: cause of disease or epiphenomenon?
Vittorio Pavoni
Lara Gianesello
Andrew Horton
Journal of Thrombosis and Thrombolysis, 2021, 52 : 542 - 552
[25] Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19
Hollerbach, Anne
Mueller-Calleja, Nadine
Pedrosa, Denise
Canisius, Antje
Sprinzl, Martin F.
Falter, Tanja
Rossmann, Heidi
Bodenstein, Marc
Werner, Christian
Sagoschen, Ingo
Muenzel, Thomas
Schreiner, Oliver
Sivanathan, Visvakanth
Reuter, Michael
Niermann, Johannes
Galle, Peter R.
Teyton, Luc
Ruf, Wolfram
Lackner, Karl J.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (09) : 2335 - 2347
[26] ANTIPHOSPHOLIPID ANTIBODIES AND OUTCOMES OF ASSISTED REPRODUCTIVE TECHNOLOGY PROGRAMS IN PATIENTS WITH A HISTORY OF COVID-19
Ermakova, D. M.
Dolgushina, N., V
Menzhinskaya, I., V
Lomova, N. A.
Vtorushina, V. V.
BULLETIN OF RUSSIAN STATE MEDICAL UNIVERSITY, 2022, (05): : 40 - 46
[27] Antiphospholipid antibodies in critically ill COVID-19 patients with thromboembolism: cause of disease or epiphenomenon?
Pavoni, Vittorio
Gianesello, Lara
Horton, Andrew
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 52 (02) : 542 - 552
[28] A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies
Ruiz-Irastorza, Guillermo
Hunt, Beverley J.
Khamashta, Munther A.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (08): : 1487 - 1495
[29] Antiphospholipid antibodies in convalescent plasma of donors recovered from mild COVID-19 infection
Blickstein, Dorit
Izak, Marina
Filipovich-Rimon, Talia
Garach-Jehoshua, Osnat
Rahimi-Levene, Naomi
Shinar, Eilat
Hamad, Ramzia Abu
Bar-Chaim, Adina
Koren-Michowitz, Maya
VOX SANGUINIS, 2023, 118 (07) : 517 - 522
[30] COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)
Wang, Xin
Gkrouzman, Elena
Andrade, Danieli Castro Oliveira
Andreoli, Laura
Barbhaiya, Medha
Belmont, H. Michael
Branch, David Ware
de Jesus, Guilherme R.
Efthymiou, Maria
Rios-Garces, Roberto
Gerosa, Maria
El Hasbani, Georges
Knight, Jason
Meroni, Pier Luigi
Pazzola, Giulia
Petri, Michelle
Rand, Jacob
Salmon, Jane
Tektonidou, Maria
Tincani, Angela
Uthman, Imad W.
Zuily, Stephane
Zuo, Yu
Lockshin, Michael
Cohen, Hannah
Erkan, Doruk
LUPUS, 2021, 30 (14) : 2276 - 2285

← 1 2 3 4 5 →